PB 53 of 2022
Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Amendment Determination 2022
National Health Act 1953
The Pharmaceutical Benefits Remuneration Tribunal makes this Determination under paragraph 98B(1)(a) of the National Health Act 1953.
Dated 1 June 2022
ABBEYGAIL BEAUMONT
Chairperson
for and on behalf of the
Pharmaceutical Benefits Remuneration Tribunal
Contents
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020
6 Definitions……………………………………………….…………………………...2
12(1) Ready‑prepared pharmaceutical benefits—administration, handling and infrastructure fee……………………………………………………………………...2
20 Extemporaneously‑prepared pharmaceutical benefits—administration, handling and infrastructure fee……………………………………………………………………...2
(1) This instrument is the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Amendment Determination 2022.
(2) This instrument may also be cited as PB 53 of 2022.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 July 2022 | 1 July 2022 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under paragraph 98B(1)(a) of the National Health Act 1953.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020
1 Part 1, Section 6 Definitions
Omit:
“dangerous drug fee means an amount of $4.82.
extemporaneously-prepared dispensing fee means an amount of $9.82.
ready-prepared dispensing fee means an amount of $7.78.”
Substitute:
“dangerous drug fee means an amount of $4.84.
extemporaneously-prepared dispensing fee means an amount of $9.86.
ready-prepared dispensing fee means an amount of $7.82.”
2 Part 2, Section 12(1)(a) (table)
Repeal the table at paragraph 12(1)(a), insert:
AHI Tier | Price to pharmacists for maximum quantity | Administration, handling and infrastructure fee for maximum quantity |
1 | < $100 | $4.32 |
2 | ≥ $100, ≤ $2 000 | Tier 1 AHI Fee + 5% of the amount by which the price to pharmacists for maximum quantity exceeds $100 |
3 | > $2 000 | $95.00 + Tier 1 AHI Fee |
3 Part 3, Section 20 (table)
Repeal the table at section 20, insert:
AHI Tier | Price to pharmacists for maximum quantity | Administration, handling and infrastructure fee |
1 | < $100 | $4.32 |
2 | ≥ $100, ≤ $2 000 | Tier 1 AHI Fee + 5% of the amount by which the price to pharmacists for maximum quantity exceeds $100 |
3 | > $2 000 | $95.00 + Tier 1 AHI Fee |